Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Launch Type 2 Diabetes Educational Game, “Complications Combat”
5/24/2013 10:07:51 AM
More...
|
Johnson & Johnson (JNJ): We're Creaming Medivation, Inc. (MDVN), Boehringer Ingelheim Corporation, Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE)
5/24/2013 8:32:02 AM
More...
|
A Boehringer Ingelheim Corporation Shake Up and an FDA Warning Letter Over Production Gaffes
5/22/2013 7:49:17 AM
More...
|
Boehringer Ingelheim Corporation Release: Phase III Results: Tiotropium* Respimat® Effective in Symptomatic Asthma Patients Despite at Least ICS†/LABA‡ Independent of Their Age, Allergic Status, Smoking Status and Bronchodilator Response
5/21/2013 10:04:35 AM
More...
|
Boehringer Ingelheim Corporation Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at American Thoracic Society 2013
5/21/2013 7:20:11 AM
More...
|
Boehringer Ingelheim Corporation's Anticoagulant Pradaxa Adds Warning to Prescribing Info
4/30/2013 10:50:54 AM
More...
|
Oxford BioTherapeutics and Boehringer Ingelheim Corporation Enter Collaboration to Discover Novel Antibody Targets in Cancer
4/29/2013 9:49:15 AM
More...
|
Boehringer Ingelheim Corporation to Restructure in Southern Europe, Jobs at Risk
4/25/2013 7:59:48 AM
More...
|
Argenta Discovery Ltd. Announces Integrated Drug Discovery Collaboration With Boehringer Ingelheim Corporation
4/17/2013 9:36:30 AM
More...
|
Boehringer Ingelheim Corporation Invests Undisclosed Amount Into Gene Therapy
4/11/2013 10:01:42 AM
More...
|
|